Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2022)
Atea Pharmaceuticals has reported Current Leases over the past 2 years, most recently at $711000.0 for Q3 2022.
- Quarterly results put Current Leases at $711000.0 for Q3 2022, changed N/A from a year ago — trailing twelve months through Sep 2022 was $711000.0 (changed N/A YoY), and the annual figure for FY2021 was $197000.0, changed.
- Current Leases for Q3 2022 was $711000.0 at Atea Pharmaceuticals, down from $730000.0 in the prior quarter.
- Over the last five years, Current Leases for AVIR hit a ceiling of $730000.0 in Q2 2022 and a floor of $113000.0 in Q1 2022.